Clinical outcomes in a cohort of patients with cutaneous T-cell lymphoma and COVID-19.
作者信息
Runge John S, Bardhi Redina, Xia Yang, Jairath Neil K, Wilcox Ryan A, Tsoi Lam C, Tejasvi Trilokraj
机构信息
Department of Dermatology, University of Michigan - Michigan Medicine, Ann Arbor, Michigan.
出版信息
JAAD Int. 2022 Sep;8:52-55. doi: 10.1016/j.jdin.2022.04.008. Epub 2022 May 3.
Abstract
摘要
相似文献
1
Clinical outcomes in a cohort of patients with cutaneous T-cell lymphoma and COVID-19.一组皮肤T细胞淋巴瘤合并新型冠状病毒肺炎患者的临床结局
JAAD Int. 2022 Sep;8:52-55. doi: 10.1016/j.jdin.2022.04.008. Epub 2022 May 3.
2
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.原发性皮肤 T 细胞淋巴瘤（蕈样肉芽肿和赛泽里综合征）：第一部分。诊断：临床和组织病理学特征以及新的分子和生物学标志物。
J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049.
3
Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator.皮肤T细胞淋巴瘤患者的瘙痒作为生活质量指标
JAAD Int. 2022 Aug 7;9:57-64. doi: 10.1016/j.jdin.2022.07.007. eCollection 2022 Dec.
4
Cutaneous T-cell lymphoma and atopy: is there an association?皮肤T细胞淋巴瘤与特应性：存在关联吗？
Br J Dermatol. 2003 Nov;149(5):1013-7. doi: 10.1111/j.1365-2133.2003.05551.x.
5
Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.蕈样肉芽肿和 Sézary 综合征累及淋巴结，酷似血管免疫母细胞性 T 细胞淋巴瘤。
Hum Pathol. 2015 Sep;46(9):1382-9. doi: 10.1016/j.humpath.2015.05.024. Epub 2015 Jun 10.
6
Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas.侵袭性皮肤 T 细胞淋巴瘤患者的生存和预后因素。
Acta Derm Venereol. 2022 Mar 22;102:adv00676. doi: 10.2340/actadv.v102.1087.
7
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.原发性皮肤 T 细胞淋巴瘤除蕈样真菌病和赛泽里综合征以外。第二部分：预后和治疗。
J Am Acad Dermatol. 2021 Nov;85(5):1093-1106. doi: 10.1016/j.jaad.2021.04.081. Epub 2021 May 1.
8
Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.皮肤T细胞淋巴瘤：西非马里蕈样肉芽肿、塞扎里综合征及人嗜T淋巴细胞病毒I型相关成人T细胞白血病（ATL）：14例临床、病理及免疫病毒学研究并复习非洲ATL病例
Leukemia. 1998 Apr;12(4):578-85. doi: 10.1038/sj.leu.2400956.
9
Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study.局部注射 TTI-621，一种新型针对固有免疫检查点 CD47 的生物制剂，用于治疗复发或难治性蕈样真菌病或塞扎里综合征患者：一项多中心、1 期研究。
Lancet Haematol. 2021 Nov;8(11):e808-e817. doi: 10.1016/S2352-3026(21)00271-4. Epub 2021 Oct 7.
10
Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome.CCR3 和 CCR4 的表达提示蕈样肉芽肿和塞扎里综合征预后不良。
Acta Derm Venereol. 2019 Jul 1;99(9):809-812. doi: 10.2340/00015555-3207.
引用本文的文献
1
The heightened impact of COVID-19 on emotional wellbeing and delays in care in patients with cutaneous T-cell lymphoma: a cross-sectional study.新型冠状病毒肺炎对皮肤T细胞淋巴瘤患者情绪健康的影响加剧及护理延迟：一项横断面研究
Arch Dermatol Res. 2025 Mar 8;317(1):530. doi: 10.1007/s00403-025-03937-1.
2
COVID-19 infection in children with blood cancer: A systematic review.血癌患儿的新冠病毒感染：一项系统综述
Ann Hematol. 2025 Feb;104(2):1203-1230. doi: 10.1007/s00277-024-06057-4. Epub 2024 Nov 5.
3
Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome.蕈样肉芽肿和塞扎里综合征 COVID-19 的临床结局。
Acta Haematol. 2023;146(6):497-504. doi: 10.1159/000531831. Epub 2023 Jul 29.
本文引用的文献
1
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.原发性皮肤淋巴瘤患者有患重症COVID-19的风险。来自西班牙原发性皮肤淋巴瘤登记处的数据。
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e624-e626. doi: 10.1111/jdv.17430. Epub 2021 Jul 2.
2
Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis.COVID-19 感染癌症患者的临床特征和结局：系统评价和荟萃分析。
J Natl Cancer Inst. 2021 Apr 6;113(4):371-380. doi: 10.1093/jnci/djaa168.
3
Cutaneous lymphomas and COVID-19: What is known so far?皮肤淋巴瘤与 COVID-19：目前已知情况有哪些？
Dermatol Ther. 2021 Jan;34(1):e14463. doi: 10.1111/dth.14463. Epub 2020 Nov 9.
4
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.COVID-19 对癌症患者的临床影响（CCC19）：一项队列研究。
Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9. Epub 2020 May 28.
5
United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic.美国皮肤淋巴瘤协会关于在2019冠状病毒病大流行期间治疗皮肤淋巴瘤的建议。
J Am Acad Dermatol. 2020 Aug;83(2):703-704. doi: 10.1016/j.jaad.2020.04.049. Epub 2020 Apr 16.
Zotero 插件